Serious dermatologic reaction associated with valdecoxib: Report of two cases - 24/08/11
Doi : 10.1016/j.jaad.2004.08.013
Sandra R. Knowles, BScPhm ⁎ 
, Elizabeth J. Phillips, MD, FRCPC, Gavin Wong, MBChB, MRCP(UK), Neil H. Shear, MD, FRCPC
, Elizabeth J. Phillips, MD, FRCPC, Gavin Wong, MBChB, MRCP(UK), Neil H. Shear, MD, FRCPC Drug Safety Clinic, Sunnybrook and Women's College, Health Sciences Centre, University of Toronto
Reprints and correspondence to: Sandra R. Knowles, BScPhm Sunnybrook and Women's College Health Sciences Centre 2075 Bayview Ave, Toronto, ON, M4N 3M5| Disclosure: Dr Shear has acted as a paid consultant to Pfizer. Dr Wong is supported by a Pfizer Canada Inc fellowship in Clinical Pharmacology from the Canadian Society of Clinical Pharmacology and is a recipient of a Ben Fisher (Galderma Canada) Clinical Fellowship. |
© 2004
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 51 - N° 6
P. 1028-1029 - décembre 2004 Retour au numéro
Article précédent
- Intravenous immune globulin in the treatment of persistent pemphigoid gestationis
- Alexander Kreuter, Ali Harati, Frank Breuckmann, Carolin Appelhans, Peter Altmeyer
- Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors
- Francesco Drago, Carlo Brusati, Giovanni Desirello, Marco Cacciapuoti, Alfredo Rebora
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?